Literature DB >> 24810284

Alternative mechanisms for respiratory syncytial virus (RSV) infection and persistence: could RSV be transmitted through the placenta and persist into developing fetal lungs?

Giovanni Piedimonte1, Miriam K Perez2.   

Abstract

PURPOSE OF REVIEW: Respiratory syncytial virus (RSV) represents the most common respiratory pathogen observed worldwide in infants and young children and may play a role in the inception of recurrent wheezing and asthma in childhood. We discuss herein the recent hypothesis that RSV vertically transmitted from the mother to the fetus in utero causes persistent structural and functional changes in the developing lungs of the offspring, thereby predisposing to postnatal airway obstruction. RECENT
FINDINGS: A number of observations in humans support the notion that extrapulmonary tissues may be infected hematogenously by RSV and harbor this virus allowing the persistence of latent infection. More recent data from animal models suggest that RSV can be transmitted across the placenta from the respiratory tract of the mother to that of the fetus, and persist in the lungs both during development, as well as during adulthood. Vertical RSV infection is associated with dysregulation of crucial neurotrophic pathways during ontogenesis, leading to aberrant parasympathetic innervation and airway hyperreactivity after postnatal reinfection.
SUMMARY: These new data challenge the current paradigm that acquisition of RSV infection occurs only after birth and shift attention to the prenatal effects of the virus, with the potential to result in more severe and lasting consequences by interfering with crucial developmental processes. The most immediate implication is that prophylactic strategies targeted to the mother-fetus dyad may reduce the incidence of postviral sequelae like childhood wheezing and asthma.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24810284      PMCID: PMC4065627          DOI: 10.1016/j.coph.2014.03.008

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  12 in total

1.  Respiratory syncytial virus infection in human bone marrow stromal cells.

Authors:  Fariba Rezaee; Laura F Gibson; Debbie Piktel; Sreekumar Othumpangat; Giovanni Piedimonte
Journal:  Am J Respir Cell Mol Biol       Date:  2010-10-22       Impact factor: 6.914

2.  Respiratory syncytial virus and recurrent wheeze in healthy preterm infants.

Authors:  Maarten O Blanken; Maroeska M Rovers; Jorine M Molenaar; Pauline L Winkler-Seinstra; Adam Meijer; Jan L L Kimpen; Louis Bont
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

3.  Detection of respiratory syncytial virus RNA in blood of neonates by polymerase chain reaction.

Authors:  A Rohwedder; O Keminer; J Forster; K Schneider; E Schneider; H Werchau
Journal:  J Med Virol       Date:  1998-04       Impact factor: 2.327

4.  Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

Authors:  N Sigurs; R Bjarnason; F Sigurbergsson; B Kjellman
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

5.  [Viremia in respiratory syncytial virus infection].

Authors:  O D Iankevich; R S Dreizin; N L Makhlinovskaia; N A Gorodnitskaia
Journal:  Vopr Virusol       Date:  1975 Jul-Aug

6.  Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.

Authors:  R T Stein; D Sherrill; W J Morgan; C J Holberg; M Halonen; L M Taussig; A L Wright; F D Martinez
Journal:  Lancet       Date:  1999-08-14       Impact factor: 79.321

Review 7.  Respiratory syncytial virus prevention and therapy: past, present, and future.

Authors:  Melvin Wright; Giovanni Piedimonte
Journal:  Pediatr Pulmonol       Date:  2010-11-23

8.  CD271(+) bone marrow mesenchymal stem cells may provide a niche for dormant Mycobacterium tuberculosis.

Authors:  Bikul Das; Suely S Kashino; Ista Pulu; Deepjyoti Kalita; Vijay Swami; Herman Yeger; Dean W Felsher; Antonio Campos-Neto
Journal:  Sci Transl Med       Date:  2013-01-30       Impact factor: 17.956

Review 9.  Extrapulmonary manifestations of severe respiratory syncytial virus infection--a systematic review.

Authors:  Michael Eisenhut
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

10.  The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children.

Authors:  Eric A F Simões; Xavier Carbonell-Estrany; Christian H L Rieger; Ian Mitchell; Linda Fredrick; Jessie R Groothuis
Journal:  J Allergy Clin Immunol       Date:  2010-07-10       Impact factor: 10.793

View more
  11 in total

1.  Discovery of Piperazinylquinoline Derivatives as Novel Respiratory Syncytial Virus Fusion Inhibitors.

Authors:  Xiufang Zheng; Lisha Wang; Baoxia Wang; Kun Miao; Kunlun Xiang; Song Feng; Lu Gao; Hong C Shen; Hongying Yun
Journal:  ACS Med Chem Lett       Date:  2016-04-20       Impact factor: 4.345

2.  Discovery of (aza)indole derivatives as novel respiratory syncytial virus fusion inhibitors.

Authors:  Xiufang Zheng; Chungen Liang; Lisha Wang; Kun Miao; Baoxia Wang; Weixing Zhang; Dongdong Chen; Guolong Wu; Wei Zhu; Lei Guo; Song Feng; Lu Gao; Hong C Shen; Hongying Yun
Journal:  Medchemcomm       Date:  2019-05-06       Impact factor: 3.597

3.  A critical role of Gas6/Axl signal in allergic airway responses during RSV vaccine-enhanced disease.

Authors:  Takehiko Shibata; Manabu Ato
Journal:  Immunol Cell Biol       Date:  2017-07-19       Impact factor: 5.126

4.  Detection of respiratory syncytial virus (RSV) at birth in a newborn with respiratory distress.

Authors:  Sara Manti; Caterina Cuppari; Angela Lanzafame; Carmelo Salpietro; Pasqua Betta; Salvatore Leonardi; Miriam K Perez; Giovanni Piedimonte
Journal:  Pediatr Pulmonol       Date:  2017-08-18

5.  Osteopontin plays a pivotal role in increasing severity of respiratory syncytial virus infection.

Authors:  Viviana Sampayo-Escobar; Ryan Green; Michael B Cheung; Raminder Bedi; Subhra Mohapatra; Shyam S Mohapatra
Journal:  PLoS One       Date:  2018-04-20       Impact factor: 3.240

6.  Burden of Respiratory Syncytial Virus Infection in South African Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Pregnant and Postpartum Women: A Longitudinal Cohort Study.

Authors:  Shabir A Madhi; Clare L Cutland; Sarah Downs; Stephanie Jones; Nadia van Niekerk; Eric A F Simoes; Marta C Nunes
Journal:  Clin Infect Dis       Date:  2018-05-17       Impact factor: 9.079

7.  Anti-Respiratory Syncytial Virus Activity of Plantago asiatica and Clerodendrum trichotomum Extracts In Vitro and In Vivo.

Authors:  Kiramage Chathuranga; Myun Soo Kim; Hyun-Cheol Lee; Tae-Hwan Kim; Jae-Hoon Kim; W A Gayan Chathuranga; Pathum Ekanayaka; H M S M Wijerathne; Won-Kyung Cho; Hong Ik Kim; Jin Yeul Ma; Jong-Soo Lee
Journal:  Viruses       Date:  2019-07-03       Impact factor: 5.048

8.  Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey: An Illustration Based on Bursa Data.

Authors:  Koen B Pouwels; Sefika E Bozdemir; Selen Yegenoglu; Solmaz Celebi; E David McIntosh; Serhat Unal; Maarten J Postma; Mustafa Hacimustafaoglu
Journal:  PLoS One       Date:  2016-09-30       Impact factor: 3.240

Review 9.  Cellular and molecular mechanisms of viral infection in the human placenta.

Authors:  Moises León-Juárez; Macario Martínez-Castillo; Luis Didier González-García; Addy Cecilia Helguera-Repetto; Verónica Zaga-Clavellina; Julio García-Cordero; Arturo Flores-Pliego; Alma Herrera-Salazar; Edgar Ricardo Vázquez-Martínez; Enrique Reyes-Muñoz
Journal:  Pathog Dis       Date:  2017-09-29       Impact factor: 3.166

Review 10.  Potential Neurocognitive Symptoms Due to Respiratory Syncytial Virus Infection.

Authors:  Catalina A Andrade; Alexis M Kalergis; Karen Bohmwald
Journal:  Pathogens       Date:  2021-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.